Biochemical characterization of Plasmodium falciparum dipeptidyl aminopeptidase 1

Molecular and Biochemical Parasitology

Volumn 175, Issue 1, 2011, Pages 10-20

  Wang, Flora ^a   Krai, Priscilla ^a   Deu, Edgar ^b   Bibb, Brittney ^a   Lauritzen, Conni ^c   Pedersen, John ^c   Bogyo, Matthew ^b   Klemba, Michael ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Unizyme Laboratories A/S   (Denmark)

Author keywords

Cathepsin; Exopeptidase; Hemoglobin; Malaria; Vacuole

Indexed keywords

CHLORIDE; DIPEPTIDYL PEPTIDASE I; PHENYLALANINE; PROLINE; RECOMBINANT ENZYME;

ACIDITY; ARTICLE; CATALYSIS; CHEMICAL BOND; COMBINATORIAL LIBRARY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; HYDROLYSIS; HYDROPHOBICITY; ORTHOLOGY; PH; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN QUATERNARY STRUCTURE;

AMINO ACIDS; CATHEPSIN C; CHLORIDES; ENZYME ACTIVATORS; FLUORESCENT DYES; HEMOGLOBINS; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; PLASMODIUM FALCIPARUM; PROTEASE INHIBITORS; PROTEIN MULTIMERIZATION; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

PLASMODIUM FALCIPARUM;

EID: 78049430317     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2010.08.004     Document Type: Article

References (58)

1. Krugliak M., Zhang J., Ginsburg H. Intraerythrocytic Plasmodium falciparum utilizes only a fraction of the amino acids derived from the digestion of host cell cytosol for the biosynthesis of its proteins. Mol Biochem Parasitol 2002, 119:249-256.
2. Loria P., Miller S., Foley M., Tilley L. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem J 1999, 339:363-370.
3. Goldberg D.E. Hemoglobin degradation. Curr Top Microbiol Immunol 2005, 295:275-291.
4. Rosenthal P.J., McKerrow J.H., Aikawa M., Nagasawa H., Leech J.H. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J Clin Invest 1988, 82:1560-1566.
5. Klemba M., Gluzman I., Goldberg D.E. A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation. J Biol Chem 2004, 279:43000-43007.
6. Dalal S., Klemba M. Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum. J Biol Chem 2007, 282:35978-35987.
7. Arastu-Kapur S., Ponder E.L., Fonovic U.P., et al. Chemically mapping protease pathways involved in the regulation of erythrocyte rupture by the human malaria parasite Plasmodium falciparum. Nat Chem Biol 2008, 4:203-213.
8. Adkison A.M., Raptis S.Z., Kelley D.G., Pham C.T. Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest 2002, 109:363-371.
9. Pham C.T., Ley T.J. Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci USA 1999, 96:8627-8632.
10. Wolters P.J., Pham C.T., Muilenburg D.J., Ley T.J., Caughey G.H. Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J Biol Chem 2001, 276:18551-18556.
11. Bondebjerg J., Fuglsang H., Valeur K.R., Pedersen J., Naerum L. Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors. Bioorg Med Chem Lett 2006, 16:3614-3617.
12. Methot N., Rubin J., Guay D., et al. Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing. J Biol Chem 2007, 282:20836-20846.
13. Olsen J.G., Kadziola A., Lauritzen C., Pedersen J., Larsen S., Dahl S.W. Tetrameric dipeptidyl peptidase I directs substrate specificity by use of the residual pro-part domain. FEBS Lett 2001, 506:201-206.
14. Turk D., Janjic V., Stern I., et al. Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J 2001, 20:6570-6582.
15. Schechter I., Berger A. On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 1967, 27:157-162.
16. Maly D.J., Leonetti F., Backes B.J., et al. Expedient solid-phase synthesis of fluorogenic protease substrates using the 7-amino-4-carbamoylmethylcoumarin (ACC) fluorophore. J Org Chem 2002, 67:910-915.
17. Bondebjerg J., Fuglsang H., Valeur K.R., et al. Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI). Bioorg Med Chem 2005, 13:4408-4424.
18. Kapust R.B., Tozser J., Fox J.D., et al. Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency. Protein Eng 2001, 14:993-1000.
19. Dahl S.W., Halkier T., Lauritzen C., et al. Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Biochemistry 2001, 40:1671-1678.
20. Harris J.L., Backes B.J., Leonetti F., Mahrus S., Ellman J.A., Craik C.S. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc Natl Acad Sci USA 2000, 97:7754-7759.
21. Dixon M. The determination of enzyme inhibitor constants. Biochem J 1953, 55:170-171.
22. Ellis K.J., Morrison J.F. Buffers of constant ionic strength for studying pH-dependent processes. Methods Enzymol 1982, 87:405-426.
23. Molgaard A., Arnau J., Lauritzen C., Larsen S., Petersen G., Pedersen J. The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2. Biochem J 2007, 401:645-650.
24. Goh L.L., Loke P., Singh M., Sim T.S. Soluble expression of a functionally active Plasmodium falciparum falcipain-2 fused to maltose-binding protein in Escherichia coli. Protein Expr Purif 2003, 32:194-201.
25. Goh S.L., Goh L.L., Sim T.S. Cysteine protease falcipain 1 in Plasmodium falciparum is biochemically distinct from its isozymes. Parasitol Res 2005, 97:295-301.
26. Kapust R.B., Tozser J., Copeland T.D., Waugh D.S. The P1' specificity of tobacco etch virus protease. Biochem Biophys Res Commun 2002, 294:949-955.
27. Bessette P.H., Aslund F., Beckwith J., Georgiou G. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci USA 1999, 96:13703-13708.
28. Lauritzen C., Pedersen J., Madsen M.T., Justesen J., Martensen P.M., Dahl S.W. Active recombinant rat dipeptidyl aminopeptidase I (cathepsin C) produced using the baculovirus expression system. Protein Expr Purif 1998, 14:434-442.
29. McDonald J.K., Reilly T.J., Zeitman B.B., Ellis S. Cathepsin C: a chloride-requiring enzyme. Biochem Biophys Res Commun 1966, 22:771-775.
30. McDonald J.K., Zeitman B.B., Reilly T.J., Ellis S. New observations on the substrate specificity of cathepsin C (dipeptidyl aminopeptidase I). Including the degradation of beta-corticotropin and other peptide hormones. J Biol Chem 1969, 244:2693-2709.
31. Cornish-Bowden A. Fundamentals of Enzyme Kinetics 2004, Portland Press, London.
32. Dolenc I., Turk B., Pungercic G., Ritonja A., Turk V. Oligomeric structure and substrate induced inhibition of human cathepsin C. J Biol Chem 1995, 270:21626-21631.
33. Nagler D.K., Tam W., Storer A.C., Krupa J.C., Mort J.S., Menard R. Interdependency of sequence and positional specificities for cysteine proteases of the papain family. Biochemistry 1999, 38:4868-4874.
34. Schneck J.L., Villa J.P., McDevitt P., McQueney M.S., Thrall S.H., Meek T.D. Chemical mechanism of a cysteine protease, cathepsin C, as revealed by integration of both steady-state and pre-steady-state solvent kinetic isotope effects. Biochemistry 2008, 47:8697-8710.
35. Bennett T.N., Kosar A.D., Ursos L.M., et al. Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. Mol Biochem Parasitol 2004, 133:99-114.
36. Klonis N., Tan O., Jackson K., Goldberg D., Klemba M., Tilley L. Evaluation of pH during cytostomal endocytosis and vacuolar catabolism of hemoglobin in Plasmodium falciparum. Biochem J 2007, 407:343-354.
37. Krogstad D.J., Schlesinger P.H., Gluzman I.Y. Antimalarials increase vesicle pH in Plasmodium falciparum. J Cell Biol 1985, 101:2302-2309.
38. Kuhn Y., Rohrbach P., Lanzer M. Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin. Cell Microbiol 2007, 9:1004-1013.
39. Storer A.C., Menard R. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol 1994, 244:486-500.
40. Fersht A. Structure and Mechanism in Protein Science 1999, W. H. Freeman and Company, New York.
41. Cigic B., Pain R.H. Location of the binding site for chloride ion activation of cathepsin C. Eur J Biochem 1999, 264:944-951.
42. McGrath M.E. The lysosomal cysteine proteases. Annu Rev Biophys Biomol Struct 1999, 28:181-204.
43. Turk D., Guncar G., Podobnik M., Turk B. Revised definition of substrate binding sites of papain-like cysteine proteases. Biol Chem 1998, 379:137-147.
44. Schneider E.L., Craik C.S. Positional scanning synthetic combinatorial libraries for substrate profiling. Methods Mol Biol 2009, 539:59-78.
45. Leiting B., Pryor K.D., Wu J.K., et al. Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII. Biochem J 2003, 371:525-532.
46. Tran T.V., Ellis K.A., Kam C.M., Hudig D., Powers J.C. Dipeptidyl peptidase I: importance of progranzyme activation sequences, other dipeptide sequences, and the N-terminal amino group of synthetic substrates for enzyme activity. Arch Biochem Biophys 2002, 403:160-170.
47. McGuire M.J., Lipsky P.E., Thiele D.L. Purification and characterization of dipeptidyl peptidase I from human spleen. Arch Biochem Biophys 1992, 295:280-288.
48. Cigic B., Krizaj I., Kralj B., Turk V., Pain R.H. Stoichiometry and heterogeneity of the pro-region chain in tetrameric human cathepsin C. Biochim Biophys Acta 1998, 1382:143-150.
49. Cigic B., Dahl S.W., Pain R.H. The residual pro-part of cathepsin C fulfills the criteria required for an intramolecular chaperone in folding and stabilizing the human proenzyme. Biochemistry 2000, 39:12382-12390.
50. Choe Y., Leonetti F., Greenbaum D.C., et al. Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J Biol Chem 2006, 281:12824-12832.
51. Subramanian S., Hardt M., Choe Y., et al. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3. PLoS ONE 2009, 4:e5156.
52. Jia Z., Hasnain S., Hirama T., et al. Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. J Biol Chem 1995, 270:5527-5533.
53. Fruton J.S., Mycek M.J. Studies on beef spleen cathepsin C. Arch Biochem Biophys 1956, 65:11-20.
54. Garnero P., Borel O., Byrjalsen I., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 1998, 273:32347-32352.
55. Lecaille F., Choe Y., Brandt W., Li Z., Craik C.S., Bromme D. Selective inhibition of the collagenolytic activity of human cathepsin K by altering its S2 subsite specificity. Biochemistry 2002, 41:8447-8454.
56. Dowd A.J., Smith A.M., McGonigle S., Dalton J.P. Purification and characterisation of a second cathepsin L proteinase secreted by the parasitic trematode Fasciola hepatica. Eur J Biochem 1994, 223:91-98.
57. Lecaille F., Chowdhury S., Purisima E., Bromme D., Lalmanach G. The S2 subsites of cathepsins K and L and their contribution to collagen degradation. Protein Sci 2007, 16:662-670.
58. Henry R.I., Cobbold S.A., Allen R.J.W., et al. An acid-loading chloride transport pathway in the intraerythrocytic malaria parasite, Plasmodium falciparum. J Biol Chem 2010, 285:18615-18626.